212 related articles for article (PubMed ID: 17581441)
21. Attention deficit hyperactivity disorder in children.
Ramchandani P; Joughin C; Zwi M
Clin Evid; 2002 Dec; (8):280-90. PubMed ID: 12603883
[No Abstract] [Full Text] [Related]
22. Methylphenidate-induced erections in a prepubertal child.
Kelly BD; Lundon DJ; McGuinness D; Brady CM
J Pediatr Urol; 2013 Feb; 9(1):e1-2. PubMed ID: 22552161
[TBL] [Abstract][Full Text] [Related]
23. Clonidine and methylphenidate.
Dech B
J Am Acad Child Adolesc Psychiatry; 1999 Dec; 38(12):1469-70. PubMed ID: 10596241
[No Abstract] [Full Text] [Related]
24. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Lee SI; Hong SD; Kim SY; Kim EJ; Kim JH; Kim JH; Park MK; Park S; Park JH; Oh EY; Lim TS; Cheong S; Cho IH; Choi JW
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):210-6. PubMed ID: 17046131
[TBL] [Abstract][Full Text] [Related]
25. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
26. Explosive outbursts associated with methylphenidate.
Adrian N
J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):618-9. PubMed ID: 11392335
[No Abstract] [Full Text] [Related]
27. [Malnutrition in children with DAMP?].
Andersen LL
Ugeskr Laeger; 2009 Mar; 171(10):824. PubMed ID: 19280776
[No Abstract] [Full Text] [Related]
28. Acute generalized exanthematous pustulosis induced by methylphenidate: a new adverse effect.
Heinzerling LM; Pichler W; Anliker MD
Arch Dermatol; 2011 Jul; 147(7):872-3. PubMed ID: 21768498
[No Abstract] [Full Text] [Related]
29. Excessive talking triggered by methylphenidate in a boy with ADHD.
Ghanizadeh A
Pharmacopsychiatry; 2009 Jan; 42(1):35-6. PubMed ID: 19153945
[No Abstract] [Full Text] [Related]
30. [Apropos the National Board and Welfare's report on ADDH: some views on the treatment with central nervous system stimulants].
Zetterström R
Lakartidningen; 2002 Aug; 99(35):3435-6. PubMed ID: 12362770
[No Abstract] [Full Text] [Related]
31. [Use of methylphenidate in adults with attention deficit disorder with hyperactivity].
Gauillard J; Castelnau C; Vacheron-Trystram MN; Cheref S; Caroli F
Encephale; 1997; 23(4):251-6. PubMed ID: 9417389
[TBL] [Abstract][Full Text] [Related]
32. Treatment of hyperactivity in children with pervasive developmental disorders.
Scahill L; Pachler M
J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):59-62. PubMed ID: 17284238
[No Abstract] [Full Text] [Related]
33. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
Wilens TE; McBurnett K; Bukstein O; McGough J; Greenhill L; Lerner M; Stein MA; Conners CK; Duby J; Newcorn J; Bailey CE; Kratochvil CJ; Coury D; Casat C; Denisco MJ; Halstead P; Bloom L; Zimmerman BA; Gu J; Cooper KM; Lynch JM
Arch Pediatr Adolesc Med; 2006 Jan; 160(1):82-90. PubMed ID: 16389216
[TBL] [Abstract][Full Text] [Related]
34. A preliminary analysis of interactive effects between common classroom contingencies and methylphenidate.
Northup J; Jones K; Broussard C; DiGiovanni G; Herring M; Fusilier I; Hanchey A
J Appl Behav Anal; 1997; 30(1):121-5. PubMed ID: 9157096
[TBL] [Abstract][Full Text] [Related]
35. No news is bad news?
J Psychosoc Nurs Ment Health Serv; 1999 Apr; 37(4):15. PubMed ID: 10218185
[No Abstract] [Full Text] [Related]
36. [Hallucinations caused by the introduction of methylphenidate at low doses].
Aguilera-Albesa S; Yoldi-Petri ME; Molins-Castiella T; Durá-Travé T
Rev Neurol; 2010 Aug; 51(4):254-5. PubMed ID: 20648469
[No Abstract] [Full Text] [Related]
37. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R
Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
[TBL] [Abstract][Full Text] [Related]
38. Methylphenidate-induced obsessive-compulsiveness.
Kouris S
J Am Acad Child Adolesc Psychiatry; 1998 Feb; 37(2):135. PubMed ID: 9473905
[No Abstract] [Full Text] [Related]
39. Update on investigation of Ritalin conspiracy.
J Psychosoc Nurs Ment Health Serv; 2001 Jan; 39(1):10. PubMed ID: 11197990
[No Abstract] [Full Text] [Related]
40. Acute dyskinesia on starting methylphenidate after risperidone withdrawal.
Hollis CP; Thompson A
Pediatr Neurol; 2007 Oct; 37(4):287-8. PubMed ID: 17903675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
